Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Reuters

08/06

Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25

Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2557312560"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557312560\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557312560?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-06 05:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557312560","market":"nz","top_or_hot":-1,"title":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArdent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-06 05:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARDT","symbol_name":"Ardent Health Partners (2024 New Filing)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL1XF8FH:1","article_id":"2557312560","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557312560","pubTimestamp":1754428164,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ARDT":"Ardent Health Partners (2024 New Filing)"},"translate_title":"Ardent Health Inc.报告2025年第二季度总收入增长11.9%，调整后EBITDA增长38.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARDT":0.9},"content_text":"Ardent Health Inc. Reports 11.9% Increase in Total Revenue and 38.9% Growth in Adjusted EBITDA for 2Q25\n    \n\n        Ardent Health Inc. has released its second quarter 2025 financial results, reporting a significant year-over-year increase in total revenue and adjusted EBITDA. Total revenue for the quarter reached $1.65 billion, marking an 11.9% growth compared to $1.47 billion in the same period last year. Adjusted EBITDA also saw a substantial rise of 38.9%, increasing from $122.3 million in the second quarter of 2024 to $169.9 million in the current quarter. Moreover, Ardent Health reported an expansion in its adjusted EBITDA margin, which grew by 200 basis points from 8.3% to 10.3%. The company experienced strong admissions growth, with a 6.6% year-over-year increase. Adjusted admissions rose 1.6% in the second quarter and have grown 2.2% year-to-date for 2025. The financial performance of Ardent Health indicates robust growth and improved operational efficiency compared to the previous year.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief on August 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}